<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01906918</url>
  </required_header>
  <id_info>
    <org_study_id>RIPC</org_study_id>
    <nct_id>NCT01906918</nct_id>
  </id_info>
  <brief_title>Application of Remote Ischemic Preconditioning in Patients Undergoing Open Heart Surgeries</brief_title>
  <official_title>Evaluation of Remote Preconditioning on Heart Resistance to Ischemia and Reperfusion Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campinas, Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Strategies for myocardial protection during open heart surgeries are desired. Several
      experimental studies have shown beneficial effects of remote ischemic preconditioning (RIPC).
      The underlying mechanisms are not totally understood. This study intends to evaluate
      molecular mechanisms involved with RIPC on myocardium of patients underwent open heart
      surgeries.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Molecular pathway activation</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammatory response</measure>
    <time_frame>10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause of mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause of mortality</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>IRPC, Remote preconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will be submitted to ischemic preconditioning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This patients will be submitted to the standard surgery protocol in the institution. The patients will not be submitted to 5 minutes of upper limb compression by cuff followed by 5 minutes of reperfusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IRPC, Remote preconditioning</intervention_name>
    <description>The patients will be submitted to 5 minutes of upper limb compression by cuff followed by 5 minutes of reperfusion. This cycle will be repeated 4 times.</description>
    <arm_group_label>IRPC, Remote preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years

          -  Scheduled for coronary artery bypass grafting with or without valve replacement
             associated

          -  Use of blood cardioplegia

          -  EuroSCORE II greater than or equal to 1.0%

        Exclusion Criteria:

          -  History of cardiogenic shock

          -  Complications in the admission

          -  Pregnant patients

          -  Severe peripheral arterial disease affecting the upper limbs

          -  Liver failure (bilirubin ˃ 20 mmol / L, INR 2.0 ˃)

          -  Significant pulmonary disease (˂ FEV1 40%)

          -  Renal failure with glomerular filtration rate ˂ ml/min/1,73 m²

          -  Concomitant treatment with glibenclamide or nicorandil (medications that interfere
             with cardioprotection induced by IPCR)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orlando Petrucci, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Campinas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fany Lima, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Campinas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orlando Petrucci, MD, PhD</last_name>
    <phone>+55 19 97253335</phone>
    <email>petrucci@cardiol.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital das Clínicas da Unicamp</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <zip>13100000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fany Lima</last_name>
      <phone>++55 (19) 3521-7131</phone>
      <email>fanyslima@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Orlando Petrucci, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fany Lima, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pedro Paulo M Oliveira, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lindemberg M Silveira-Filho, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karlos AS Vilarinho, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elaine S Severino, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela D Carvalho, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2013</study_first_submitted>
  <study_first_submitted_qc>July 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2013</study_first_posted>
  <last_update_submitted>November 27, 2013</last_update_submitted>
  <last_update_submitted_qc>November 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campinas, Brazil</investigator_affiliation>
    <investigator_full_name>Orlando Petrucci</investigator_full_name>
    <investigator_title>Phd</investigator_title>
  </responsible_party>
  <keyword>ischemia</keyword>
  <keyword>reperfusion</keyword>
  <keyword>myocardial ischemia</keyword>
  <keyword>myocardial reperfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

